IDSA
@idsainfo.bsky.social
A global community of 13,000 clinicians, scientists and public health experts working together to solve humanity’s smallest and greatest challenges, from tiny microbes to global outbreaks.
🌍 Kick off #IMARI26 with an opening ceremony feat. experts + patient advocates on the challenges and opportunities of AMR – foreshadowing the inspiring expert conversations to come.
💡 Learn more: https://imari.org/program
🥳 Join us: imari.org/registration
💡 Learn more: https://imari.org/program
🥳 Join us: imari.org/registration
December 28, 2025 at 1:31 AM
🌍 Kick off #IMARI26 with an opening ceremony feat. experts + patient advocates on the challenges and opportunities of AMR – foreshadowing the inspiring expert conversations to come.
💡 Learn more: https://imari.org/program
🥳 Join us: imari.org/registration
💡 Learn more: https://imari.org/program
🥳 Join us: imari.org/registration
Happy holidays from IDSA! ❄️ We are grateful for our global community of clinicians, scientists and public health experts whose compassion and commitment to science and health equity help protect individuals, communities and the world.
December 25, 2025 at 5:21 PM
Happy holidays from IDSA! ❄️ We are grateful for our global community of clinicians, scientists and public health experts whose compassion and commitment to science and health equity help protect individuals, communities and the world.
On IDSA’s & HIVMA’s Science Speaks blog: A study in The Lancet addressed cloxacillin versus cefazolin for methicillin-susceptible S. aureus bacteremia. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. www.idsociety.org/science-spea...
Anti-staphylococcal penicillins versus cefazolin for methicillin-susceptible S. aureus bacteremia: Is there a role for determining blaZ type?
A study in The Lancet addressed cloxacillin versus cefazolin for methicillin-susceptible S. aureus bacteremia. Read IDSA’s Journal Club review by Christopher J. Graber.
www.idsociety.org
December 24, 2025 at 11:13 PM
On IDSA’s & HIVMA’s Science Speaks blog: A study in The Lancet addressed cloxacillin versus cefazolin for methicillin-susceptible S. aureus bacteremia. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. www.idsociety.org/science-spea...
An ongoing increase in gonorrhoea positivity rates among young women was observed in the Netherlands since Sept. 2022.
To gain more insight, OFID authors investigated the molecular diversity, clustering and transmission of Neisseria gonorrhoeae (Ng) related to the increase. https://bit.ly/4qixcSN
To gain more insight, OFID authors investigated the molecular diversity, clustering and transmission of Neisseria gonorrhoeae (Ng) related to the increase. https://bit.ly/4qixcSN
Neisseria gonorrhoeae sequence types during increase of gonorrhoea among young women in 2022 and 2023 in the Netherlands
AbstractBackground. Since September 2022, an ongoing increase in gonorrhoea positivity rates and diagnoses among young women visiting Sexual Health Centres
academic.oup.com
December 23, 2025 at 5:45 PM
An ongoing increase in gonorrhoea positivity rates among young women was observed in the Netherlands since Sept. 2022.
To gain more insight, OFID authors investigated the molecular diversity, clustering and transmission of Neisseria gonorrhoeae (Ng) related to the increase. https://bit.ly/4qixcSN
To gain more insight, OFID authors investigated the molecular diversity, clustering and transmission of Neisseria gonorrhoeae (Ng) related to the increase. https://bit.ly/4qixcSN
A free, accredited webinar, “Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease” is available on-demand through the IDSA Academy! Learn about recommendations for the use of statin therapy in people with #HIV and more.
Access: https://bit.ly/4seJUnI
Access: https://bit.ly/4seJUnI
Webinar: Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease | IDSA Academy
Webinar: Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease Overview Faculty Accreditation Register/Take course Learn about new recommendations for the use of statin therapy in people with HIV, its potential to reduce cardi...
academy.idsociety.org
December 22, 2025 at 5:07 PM
A free, accredited webinar, “Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease” is available on-demand through the IDSA Academy! Learn about recommendations for the use of statin therapy in people with #HIV and more.
Access: https://bit.ly/4seJUnI
Access: https://bit.ly/4seJUnI
Tomorrow, Dec. 22 at 4pm ET! Join IDSA guideline authors as they can share how to apply IDSA respiratory virus vaccination guidelines in practice: https://bit.ly/3MSmCnb
December 21, 2025 at 8:36 PM
Tomorrow, Dec. 22 at 4pm ET! Join IDSA guideline authors as they can share how to apply IDSA respiratory virus vaccination guidelines in practice: https://bit.ly/3MSmCnb
💊 Optimize antimicrobial development with PK-PD insights
Join the IMARI 26 pre-meeting workshop “Translating Pharmacokinetics and Pharmacodynamics to Optimize Antimicrobial Development” with Shields, Tängdén & Andes.
📅 Add it when you register ➡️ imari.org/registration
Join the IMARI 26 pre-meeting workshop “Translating Pharmacokinetics and Pharmacodynamics to Optimize Antimicrobial Development” with Shields, Tängdén & Andes.
📅 Add it when you register ➡️ imari.org/registration
December 20, 2025 at 7:34 PM
💊 Optimize antimicrobial development with PK-PD insights
Join the IMARI 26 pre-meeting workshop “Translating Pharmacokinetics and Pharmacodynamics to Optimize Antimicrobial Development” with Shields, Tängdén & Andes.
📅 Add it when you register ➡️ imari.org/registration
Join the IMARI 26 pre-meeting workshop “Translating Pharmacokinetics and Pharmacodynamics to Optimize Antimicrobial Development” with Shields, Tängdén & Andes.
📅 Add it when you register ➡️ imari.org/registration
Join IDSA guideline authors next Mon. Dec. 22 at 4pm ET to learn how to apply IDSA respiratory virus vaccination guidelines in practice: https://bit.ly/3MSmCnb
December 20, 2025 at 12:25 AM
Join IDSA guideline authors next Mon. Dec. 22 at 4pm ET to learn how to apply IDSA respiratory virus vaccination guidelines in practice: https://bit.ly/3MSmCnb
IDSA has selected Jeanne Marrazzo, MD, MPH, FIDSA, as its next chief executive officer, effective Jan. 12, 2026.
Learn more: bit.ly/4pHt2nF
Learn more: bit.ly/4pHt2nF
December 18, 2025 at 7:35 PM
IDSA has selected Jeanne Marrazzo, MD, MPH, FIDSA, as its next chief executive officer, effective Jan. 12, 2026.
Learn more: bit.ly/4pHt2nF
Learn more: bit.ly/4pHt2nF
Advancing the future of infectious diseases starts with your support. Through Dec. 31, gifts are matched dollar-for-dollar until we reach our goal of $100,000, helping fuel mentorship, research and education for the next generation of ID experts.
Donate today: https://bit.ly/3KuTRvX
Donate today: https://bit.ly/3KuTRvX
December 18, 2025 at 4:05 PM
Advancing the future of infectious diseases starts with your support. Through Dec. 31, gifts are matched dollar-for-dollar until we reach our goal of $100,000, helping fuel mentorship, research and education for the next generation of ID experts.
Donate today: https://bit.ly/3KuTRvX
Donate today: https://bit.ly/3KuTRvX
⏰TOMORROW! ID fellows: Join us for a virtual Fellows Case Conference TOMORROW, Thurs. Dec. 18 at 4pm ET. This session will incl. an interesting case presentation and small group discussion, featuring Jason Barker, MD, and Caitlin Bettger, MD, as faculty discussants.
Register: https://bit.ly/4oUa6RB
Register: https://bit.ly/4oUa6RB
December 17, 2025 at 8:54 PM
⏰TOMORROW! ID fellows: Join us for a virtual Fellows Case Conference TOMORROW, Thurs. Dec. 18 at 4pm ET. This session will incl. an interesting case presentation and small group discussion, featuring Jason Barker, MD, and Caitlin Bettger, MD, as faculty discussants.
Register: https://bit.ly/4oUa6RB
Register: https://bit.ly/4oUa6RB
Women with #HIV (WWH) experience early onset menopause and symptoms may impact antiretroviral therapy (ART) adherence. In CID, authors test whether vaginal estradiol would improve genitourinary syndrome of menopause symptoms in menopausal WWH. https://bit.ly/4siiP31
Impact of vaginal estradiol on the genitourinary syndrome of menopause, vaginal microbiome and mucosal immune mediators in women living with HIV
AbstractBackground. Women with HIV (WWH) experience early onset menopause and symptoms may impact antiretroviral therapy (ART) adherence. Vaginal estradiol
academic.oup.com
December 16, 2025 at 11:45 PM
Women with #HIV (WWH) experience early onset menopause and symptoms may impact antiretroviral therapy (ART) adherence. In CID, authors test whether vaginal estradiol would improve genitourinary syndrome of menopause symptoms in menopausal WWH. https://bit.ly/4siiP31
🚨FIDSA applications are due this Friday! Apply to become a Fellow of IDSA (FIDSA) by Dec. 19: https://bit.ly/4qVcnOv
FIDSA is a designation that recognizes individuals who have achieved professional excellence and provided significant service to the profession.
FIDSA is a designation that recognizes individuals who have achieved professional excellence and provided significant service to the profession.
December 16, 2025 at 10:52 PM
🚨FIDSA applications are due this Friday! Apply to become a Fellow of IDSA (FIDSA) by Dec. 19: https://bit.ly/4qVcnOv
FIDSA is a designation that recognizes individuals who have achieved professional excellence and provided significant service to the profession.
FIDSA is a designation that recognizes individuals who have achieved professional excellence and provided significant service to the profession.
New Let’s Talk ID episode out now! 🎙️ @paulsaxmd.bsky.social sits down with infectious disease and critical care physician @mbrigmon.bsky.social of @uthealthsa.bsky.social to discuss forging a career in ID Critical Care.
Available on all podcast apps. Transcript: www.idsociety.org/multimedia/p...
Available on all podcast apps. Transcript: www.idsociety.org/multimedia/p...
Charting a Path in ID Critical Care
Paul Sax, MD, FIDSA, sits down with infectious disease and critical care physician, Matthew Brigmon, MD, discuss forging a career in ID Critical Care.
www.idsociety.org
December 15, 2025 at 4:35 PM
New Let’s Talk ID episode out now! 🎙️ @paulsaxmd.bsky.social sits down with infectious disease and critical care physician @mbrigmon.bsky.social of @uthealthsa.bsky.social to discuss forging a career in ID Critical Care.
Available on all podcast apps. Transcript: www.idsociety.org/multimedia/p...
Available on all podcast apps. Transcript: www.idsociety.org/multimedia/p...
On IDSA’s & HIVMA’s Science Speaks blog: Miriam Barshak, MD, FIDSA, senior author of IDSA’s updated guideline for diagnosing group A streptococcal pharyngitis, answers questions about the recommendations and highlights key updates. bit.ly/4qc1OWl
Diagnosing group A streptococcal pharyngitis: Updated guideline Q&A
bit.ly
December 15, 2025 at 3:02 AM
On IDSA’s & HIVMA’s Science Speaks blog: Miriam Barshak, MD, FIDSA, senior author of IDSA’s updated guideline for diagnosing group A streptococcal pharyngitis, answers questions about the recommendations and highlights key updates. bit.ly/4qc1OWl
Advancing the future of infectious diseases starts with your support. Through Dec. 31, gifts are matched dollar-for-dollar until we reach our goal of $100,000, helping fuel mentorship, research and education for the next generation of ID experts.
Donate today: https://bit.ly/3KuTRvX
Donate today: https://bit.ly/3KuTRvX
December 14, 2025 at 6:24 PM
Advancing the future of infectious diseases starts with your support. Through Dec. 31, gifts are matched dollar-for-dollar until we reach our goal of $100,000, helping fuel mentorship, research and education for the next generation of ID experts.
Donate today: https://bit.ly/3KuTRvX
Donate today: https://bit.ly/3KuTRvX
Get recognized for your impact on the field of ID. Apply to become a Fellow of IDSA (FIDSA).
FIDSA is a designation that recognizes individuals who have achieved professional excellence and provided significant service to the profession.
Apply by next Fri. Dec. 19: https://bit.ly/4qVcnOv
FIDSA is a designation that recognizes individuals who have achieved professional excellence and provided significant service to the profession.
Apply by next Fri. Dec. 19: https://bit.ly/4qVcnOv
December 12, 2025 at 9:12 PM
Get recognized for your impact on the field of ID. Apply to become a Fellow of IDSA (FIDSA).
FIDSA is a designation that recognizes individuals who have achieved professional excellence and provided significant service to the profession.
Apply by next Fri. Dec. 19: https://bit.ly/4qVcnOv
FIDSA is a designation that recognizes individuals who have achieved professional excellence and provided significant service to the profession.
Apply by next Fri. Dec. 19: https://bit.ly/4qVcnOv
ID fellows: Join us for a virtual Fellows Case Conference next Thurs. Dec. 18 at 4pm ET! This session will include an interesting case presentation and small group discussion, featuring Jason Barker, MD, and Caitlin (Cate) Bettger, MD, as faculty discussants.
Register: https://bit.ly/4oUa6RB
Register: https://bit.ly/4oUa6RB
December 11, 2025 at 9:15 PM
ID fellows: Join us for a virtual Fellows Case Conference next Thurs. Dec. 18 at 4pm ET! This session will include an interesting case presentation and small group discussion, featuring Jason Barker, MD, and Caitlin (Cate) Bettger, MD, as faculty discussants.
Register: https://bit.ly/4oUa6RB
Register: https://bit.ly/4oUa6RB
December 11, 2025 at 2:20 PM
"The current leadership lacks the bedside experience necessary to understand the damage these confusing messages send to real families," said IDSA President Ronald Nahass, MD, MHCM, FIDSA, warning of the implications of the December Advisory Committee on Immunization Practices (ACIP) meeting.
December 10, 2025 at 4:06 PM
"The current leadership lacks the bedside experience necessary to understand the damage these confusing messages send to real families," said IDSA President Ronald Nahass, MD, MHCM, FIDSA, warning of the implications of the December Advisory Committee on Immunization Practices (ACIP) meeting.
On IDSA’s & HIVMA’s Science Speaks blog: Erica Kaufman West, MD, FACP, FIDSA, reviews a study in Clinical Infectious Diseases investigating dolutegravir/lamivudine for maintenance treatment for people with #HIV and previous lamivudine resistance. https://bit.ly/3Ms62dM
Seeing is believing? DTG/3TC in patients with HIV with lamivudine resistance mutations
A study in CID investigated dolutegravir/lamivudine for maintenance treatment for people with HIV and previous lamivudine resistance. Read IDSA’s Journal Club review by Erica Kaufman West, MD, FACP, F...
www.idsociety.org
December 10, 2025 at 3:46 PM
On IDSA’s & HIVMA’s Science Speaks blog: Erica Kaufman West, MD, FACP, FIDSA, reviews a study in Clinical Infectious Diseases investigating dolutegravir/lamivudine for maintenance treatment for people with #HIV and previous lamivudine resistance. https://bit.ly/3Ms62dM
Join us at 1pm ET this Thur. Dec. 11 for a Bartlett webinar examining new evidence on high-dose influenza vaccination in older adults. Learn how recent data informs vaccine selection and strategies to reduce influenza-related hospitalizations.
Register: https://bit.ly/48TVPPY
Sponsored by Sanofi
Register: https://bit.ly/48TVPPY
Sponsored by Sanofi
December 10, 2025 at 2:00 AM
Join us at 1pm ET this Thur. Dec. 11 for a Bartlett webinar examining new evidence on high-dose influenza vaccination in older adults. Learn how recent data informs vaccine selection and strategies to reduce influenza-related hospitalizations.
Register: https://bit.ly/48TVPPY
Sponsored by Sanofi
Register: https://bit.ly/48TVPPY
Sponsored by Sanofi
Tuberculosis infection is a driver of the global TB epidemic. In CID, authors evaluated the diagnostic performance of the STANDARD F TB-Feron FIA (TB-Feron), a near-point-of-care (POC) assay for detecting TB infection. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf561/8341627
Diagnostic Accuracy of the STANDARD F TB-Feron FIA Assay for Tuberculosis Infection in Vietnam: A Cross-Sectional Study
The study evaluated the diagnostic performance of the near-point-of-care TB-Feron assay in Vietnam, demonstrating high sensitivity and good reproducibility
academic.oup.com
December 9, 2025 at 10:13 PM
Tuberculosis infection is a driver of the global TB epidemic. In CID, authors evaluated the diagnostic performance of the STANDARD F TB-Feron FIA (TB-Feron), a near-point-of-care (POC) assay for detecting TB infection. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf561/8341627
📝 Do you have all the credits you need? IDSA’s Academy offers a variety of maintenance of certification modules, an advocacy learning series, an antimicrobial stewardship curriculum & more.
Earn points through the IDSA Academy by Dec. 31 to maintain your certification status: https://bit.ly/3YlSu61
Earn points through the IDSA Academy by Dec. 31 to maintain your certification status: https://bit.ly/3YlSu61
IDSA Academy |
academy.idsociety.org
December 8, 2025 at 11:28 PM
📝 Do you have all the credits you need? IDSA’s Academy offers a variety of maintenance of certification modules, an advocacy learning series, an antimicrobial stewardship curriculum & more.
Earn points through the IDSA Academy by Dec. 31 to maintain your certification status: https://bit.ly/3YlSu61
Earn points through the IDSA Academy by Dec. 31 to maintain your certification status: https://bit.ly/3YlSu61
Join us for a Bartlett webinar examining new evidence on high-dose influenza vaccination in older adults. Learn how recent data informs vaccine selection and strategies to reduce influenza-related hospitalizations.
Register today: https://bit.ly/48TVPPY
Sponsored by Sanofi
Register today: https://bit.ly/48TVPPY
Sponsored by Sanofi
December 7, 2025 at 6:20 PM
Join us for a Bartlett webinar examining new evidence on high-dose influenza vaccination in older adults. Learn how recent data informs vaccine selection and strategies to reduce influenza-related hospitalizations.
Register today: https://bit.ly/48TVPPY
Sponsored by Sanofi
Register today: https://bit.ly/48TVPPY
Sponsored by Sanofi